Swiss Markets Slide 1.75% as Pharma Woes, Geopolitics & Economic Data Shape Outlook
Swiss markets fell 1.75% as pharma stocks like Roche and Novartis slid on regulatory fears, while tech and logistics gains offer a silver lining amid geopolitical uncertainty.
3 minutes to read